Masses in Young Patients - International Ovarian Tumour Analysis (MY-IOTA)

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Nov 14, 2024

Keywords

ClinConnect Summary

The MY-IOTA trial is a study focused on understanding ovarian masses in young girls and adolescents, specifically those aged 20 and under. The goal of the trial is to test and confirm certain guidelines that help doctors determine whether these masses are likely to be benign (non-cancerous) or malignant (cancerous). Researchers will also look at how accurate ultrasound tests are in diagnosing these masses and will assess any complications that may arise from treating these conditions without surgery.

To be eligible for the study, participants must be newly diagnosed with an adnexal mass, which is a growth that can occur near the ovaries. However, girls with certain conditions, such as confirmed non-adnexal masses or who are pregnant, cannot participate. During the study, participants will receive routine care and monitoring, and their experiences will help improve understanding and treatment of these conditions in young patients. The study is currently looking for volunteers to join.

Gender

FEMALE

Eligibility criteria

• • Inclusion Criteria:
• • All newly diagnosed adnexal masses identified in a girl or adolescent aged 20 or under.
• • Exclusion Criteria:
• Participants eligible for this study must not meet any of the following criteria:
• • Non-adnexal masses e.g. peritoneal inclusion cysts (where diagnosis is certain) and peritoneal carcinomatosis with no adnexal mass;
• • The denial or withdrawal of written informed consent.
• • Pregnancy at any timepoint during the study period
• • In premenarchal participants: follicle measuring \<10mm